BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27183027)

  • 1. Immunotherapy for genitourinary cancer: state of the art and new perspectives.
    Cattrini C; Dellepiane C; Cavo A; Buzzatti G; Tolomeo F; Messina C; Boccardo F
    Anticancer Drugs; 2016 Aug; 27(7):585-99. PubMed ID: 27183027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Landscape of Immunotherapy in Genitourinary Malignancies.
    Alhalabi O; Rafei H; Bilen MA; Shah AY
    Adv Exp Med Biol; 2020; 1244():107-147. PubMed ID: 32301013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy advances in uro-genital malignancies.
    Ratta R; Zappasodi R; Raggi D; Grassi P; Verzoni E; Necchi A; Di Nicola M; Salvioni R; de Braud F; Procopio G
    Crit Rev Oncol Hematol; 2016 Sep; 105():52-64. PubMed ID: 27372200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for immunotherapy in genitourinary malignancies.
    Slovin SF
    Urol Oncol; 2016 Apr; 34(4):205-13. PubMed ID: 25791754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for genitourinary malignancies in the here and now!
    Slovin SF
    Urol Oncol; 2016 Apr; 34(4):169-70. PubMed ID: 26705103
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination immunotherapy in genitourinary malignancies.
    Hoffman-Censits J; Wilde L
    Curr Opin Urol; 2016 Nov; 26(6):523-8. PubMed ID: 27517637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel immunotherapy combinations for genitourinary cancers.
    Al Harthy M; Redman J; Madan RA
    Expert Opin Biol Ther; 2020 Mar; 20(3):253-262. PubMed ID: 31914333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in genitourinary malignancies.
    Wattenberg MM; Fong L; Madan RA; Gulley JL
    Curr Opin Urol; 2016 Nov; 26(6):501-7. PubMed ID: 27471994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy for the treatment of patients with genitourinary cancers: Review and perspectives].
    Bigot F; Bonnet C; Massard C
    Bull Cancer; 2017 Apr; 104(4):370-379. PubMed ID: 28237355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation T-cell therapy for genitourinary malignancies, part A: Introduction and current state of the art.
    Pantuck M; Palaskas N; Drakaki A
    Cancer Treat Res Commun; 2018; 17():8-12. PubMed ID: 30173005
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.
    Marciscano AE; Madan RA
    Curr Treat Options Oncol; 2018 Mar; 19(3):16. PubMed ID: 29520448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy and gene therapy for genitourinary malignancies.
    Sokoloff MH; Belldegrun A
    Int J Urol; 1996 Jan; 3(1 Suppl):S4-18. PubMed ID: 24304019
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors.
    Carrozza F; Santoni M; Piva F; Cheng L; Lopez-Beltran A; Scarpelli M; Montironi R; Battelli N; Tamberi S
    Crit Rev Oncol Hematol; 2018 Nov; 131():1-6. PubMed ID: 30293699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and immune-based therapies for genitourinary malignancies: current status and future prospects.
    Zisman A; Pantuck AJ; Belldegrun A
    Isr Med Assoc J; 2000 Jan; 2(1):33-42. PubMed ID: 10892369
    [No Abstract]   [Full Text] [Related]  

  • 15. Next generation T-cell therapy for genitourinary malignancies, part B: Overcoming obstacles and future strategies for success.
    Pantuck M; Palaskas N; Drakaki A
    Cancer Treat Res Commun; 2018; 17():1-7. PubMed ID: 30170288
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy in genitourinary cancers: achievements and perspectives.
    Xylinas E; RoumiguiƩ M; Sargos P
    World J Urol; 2021 May; 39(5):1317. PubMed ID: 34003335
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy in genitourinary neoplasia.
    Droller MJ
    Urol Clin North Am; 1984 Nov; 11(4):643-57. PubMed ID: 6209844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immunotherapy: new applications in urologic oncology.
    Mullane SA; Bellmunt J
    Curr Opin Urol; 2016 Nov; 26(6):556-63. PubMed ID: 27584023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging therapeutic agents for genitourinary cancers.
    Zarrabi K; Paroya A; Wu S
    J Hematol Oncol; 2019 Sep; 12(1):89. PubMed ID: 31484560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in genitourinary neoplasia.
    Droller MJ
    J Urol; 1985 Jan; 133(1):1-5. PubMed ID: 2578065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.